Account Based Marketing Strategy for Medtech Starts With Sales Alignment Before Any Platform Purchase

An account based marketing strategy for medtech starts with a shared list of best-fit accounts and a plan built with sales. A platform comes later. Tyler Pleiss, who ran growth marketing at Clary when we recorded, says you can begin with no budget at all.

Your CEO approves ABM. You get budget, a platform quote and a quarter to show results. Then the KPIs you promised don't arrive, and the board decides ABM doesn't work.

Key Takeaways

• Tyler Pleiss, who has spent four years specializing in ABM, says you can start an account based strategy with no budget.
• Pleiss uses a pilot of 100 best-fit accounts for one quarter as his example before any tech purchase.
• Pleiss judges a best customer on retention, product usage and account health alongside contract value.
• Sales reps told Pleiss again and again that they don't know how to prioritize accounts or where to start.
• Pleiss follows a crawl, walk, run path, with the platform arriving only after the pilot proves value.
• I opened the episode warning that unrealistic ABM KPIs burn boards and make it harder for marketers who run it well.

What Is an Account Based Marketing Strategy for Medtech?

An account based marketing strategy is a cross-functional plan to focus marketing, sales and customer success on your best-fit accounts. Pleiss argues it needs no platform to start, only a shared account list, aligned messaging and the time to run it.

I interviewed Tyler Pleiss, who runs growth marketing at Clary and has spent nine years in B2B marketing, on an episode about how to do account based marketing in medtech. Pleiss said:

"You could literally start an account based strategy with no budget. You don't even need a budget to start ABM. You just need time and you need dedication and you need alignment with your sales and CS teams."

That surprises most medtech marketers, because the usual ABM pitch starts with a platform price. Pleiss told me he spent a year at Terminus, an ABM platform company, and he still tells buyers to wait.

On the episode, Pleiss described what he told prospects on those calls.

"You need a strategy first. You need to understand how you're going to create and implement an account-based strategy first."

So the first deliverable is an account list, a messaging plan and an agreement with sales about who does what. A webinar with an existing customer, executive outreach and sponsored LinkedIn content all work without a platform.

How Do You Choose the Best Accounts to Target?

Choose accounts by looking at your best existing customers, then find prospects that share their traits. Pleiss says the best customer is rarely the one with the biggest contract, so he checks retention, product usage and account health alongside contract value.

Pleiss explained how he judges a customer.

"I love looking at not just contract value but retention rate. I look at product usage, how many products are they using, and then really what's their account health looking like."

Medtech needs its own translation of that. Implant companies can watch product expansion. For capital equipment, I'd watch utilization instead.

Picture two urology accounts. One has five urologists, each using your technology 60 to 70 percent of the time. The other has one urologist using it every time.

Which account is better depends on what you want to learn, and that's the decision ABM forces you to make deliberately.

I'd also look beyond the clinician. Hospitals are no longer places where you sell to the doctor and you're done, so the C-suite, supply chain and procurement belong in your account profile.

For more on that buying committee, read my guide to selling to a hospital value analysis committee.

Why Do Medtech Reps Need ABM to Prioritize a Thousand Accounts?

Reps need ABM because they can't work a thousand accounts at once. A shared target list tells them where to spend their time and what to say, and it gives marketing a specific group to support.

Pleiss described the situation he hears from sales leaders.

"The number one thing is always, I don't know how to prioritize my accounts, I don't know where to start."

He then added the second half of the problem, which is messaging. Reps need a list and they need to know what to say to a biotech account or a hospital account. Customer data shows which product use cases to lead with.

That's why alignment comes first. Pleiss told me the first thing he does at any company is book 30 minutes with the VP of sales, the director and every rep.

He then sets an operational rhythm of recurring meetings, either biweekly or monthly, with a pod of reps or the sales leader.

It sounds basic. I think that's the point.

How Do You Pilot Account Based Marketing Without Getting the Board Burned?

Run a small pilot. Prove value on a short list of accounts in a quarter, and add technology only once the motion works across more than one sales team, as Pleiss recommends.

I opened that episode saying ABM is often the thing medtech companies spend a lot of money on without knowing what they're doing.

When a marketer sets unrealistic KPIs for a first ABM program, the CEO and board get burned. Then the next marketer who proposes ABM, with a real plan, gets shot down.

Pleiss framed the safer path as crawl, walk, run.

"Strategy first, tech further down the line."

• In the crawl stage, you build a pilot with a short list, sales alignment and a reporting rhythm.
• In the walk stage, you add channels you already own.
• In the run stage, you bring in a platform for automation and data across teams.

I'd add one rule. Write down what success looks like before the pilot starts, in terms your board already understands, such as meetings booked at the target accounts and movement through your pipeline.

What Does an Account Based Marketing Strategy Mean for Medtech Founders?

It means ABM is a strategy decision before it's a budget line. If you can't name the 100 accounts you want most, and the person in sales who owns each relationship, you aren't ready for a platform.

In my experience working with medtech founders, the missing piece is usually a market narrative the accounts already recognize. Clinical validation isn't commercial traction, and FDA clearance is the starting line, not the finish line.

An account list with no narrative behind it turns into outbound noise.

At MarketCraft, we build the narrative that makes target accounts understand why your category matters, so sales calls don't start from zero. Great companies don't wait for markets to form. They engineer them.

Here's how I'd start this quarter:

• Pull your best customers and rank them on retention, usage and account health.
• Choose 100 look-alike accounts, as Pleiss does in his example.
• Meet with every rep and set a recurring rhythm.
• Run the pilot on channels you already own.

For related reading, see how B2B demand strategies move a medtech pipeline and what medical device sales requires once the market is engineered. On The State of MedTech, I keep coming back to this idea because boards remember the program that failed.

Frequently Asked Questions

What is an account based marketing strategy for medtech?

It's a plan where marketing, sales and customer success focus on the same best-fit accounts. Each account gets tailored messaging and outreach instead of broad campaigns.

Pleiss calls it a cross-functional strategy built around the accounts that look like your best customers. The focus matters more than any single tactic or tool.

Do you need an ABM platform to start?

No. Pleiss tells teams they don't need a platform at the start and should build the strategy first.

You can run a pilot with a target list, aligned sales messaging, sponsored social ads and customer webinars. Add technology only after the pilot shows results and you want to scale across more teams.

How do you pick the best accounts for ABM?

Start with your best customers and look at retention, product usage and account health alongside contract value. Ask customer success which clients are a pleasure to work with.

Then find prospects with similar traits. In medtech, add utilization, the hospital's wider buying committee and the supply chain contacts who influence purchasing.

Is ABM different from inbound marketing?

They work together. Pleiss says every company needs an inbound strategy that reaches a wider audience and creates demand.

ABM adds a focused layer for the accounts that matter most to sales. It gives reps a short list and gives marketing a clear group to support with relevant content.

Where Should You Go From Here?

If you're doing this yourself. Pull your best customers and choose a 100-account pilot using the commercial plan in the medtech commercialization strategy guide. Listen to The State of MedTech for how other operators run sales and marketing together.

If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. We'd look at which accounts to target and what market narrative they need to hear.

Listen to Tyler Pleiss's Full Story

Tyler Pleiss's full conversation with Omar Khateeb is available on The State of MedTech. Watch on YouTube. Subscribe wherever you listen to podcasts.

About Tyler Pleiss

Tyler Pleiss is a B2B marketer with nine years of experience, including four focused on account based marketing. He spent a year at ABM platform provider Terminus and then built account based programs for strategic industries at Clary.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry. He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth.

Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.